A detailed history of Tredje Ap Fonden transactions in Incyte Corp stock. As of the latest transaction made, Tredje Ap Fonden holds 29,689 shares of INCY stock, worth $2.08 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,689
Previous 29,689 -0.0%
Holding current value
$2.08 Million
Previous $1.8 Million 9.06%
% of portfolio
0.02%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$51.18 - $63.75 $23,952 - $29,835
-468 Reduced 1.55%
29,689 $1.8 Million
Q4 2023

Feb 12, 2024

SELL
$52.16 - $64.19 $59,358 - $73,048
-1,138 Reduced 3.64%
30,157 $1.89 Million
Q3 2023

Nov 09, 2023

SELL
$57.77 - $65.93 $168,226 - $191,988
-2,912 Reduced 8.51%
31,295 $1.81 Million
Q2 2023

Aug 11, 2023

SELL
$60.95 - $75.51 $359,117 - $444,904
-5,892 Reduced 14.69%
34,207 $2.13 Million
Q1 2023

May 10, 2023

BUY
$70.23 - $86.01 $131,891 - $161,526
1,878 Added 4.91%
40,099 $2.9 Million
Q4 2022

Feb 10, 2023

BUY
$67.18 - $84.11 $71,613 - $89,661
1,066 Added 2.87%
38,221 $3.07 Million
Q3 2022

Nov 10, 2022

BUY
$66.18 - $82.86 $2.46 Million - $3.08 Million
37,155 New
37,155 $2.48 Million
Q4 2020

Feb 12, 2021

SELL
$80.74 - $97.7 $1.08 Million - $1.3 Million
-13,332 Closed
0 $0
Q1 2020

May 11, 2020

SELL
$63.18 - $85.97 $1.05 Million - $1.43 Million
-16,620 Reduced 55.49%
13,332 $2.24 Million
Q4 2019

Feb 10, 2020

BUY
$73.04 - $95.72 $941,485 - $1.23 Million
12,890 Added 75.55%
29,952 $2.62 Million
Q3 2019

Nov 12, 2019

BUY
$72.82 - $86.52 $349,681 - $415,469
4,802 Added 39.17%
17,062 $1.27 Million
Q1 2019

May 10, 2019

BUY
$63.56 - $88.17 $59,492 - $82,527
936 Added 8.27%
12,260 $1.05 Million
Q4 2018

Feb 11, 2019

BUY
$58.5 - $69.94 $15,736 - $18,813
269 Added 2.43%
11,324 $720,000
Q2 2018

Aug 09, 2018

SELL
$60.85 - $83.98 $87,076 - $120,175
-1,431 Reduced 11.46%
11,055 $741,000
Q1 2018

May 09, 2018

BUY
$83.06 - $100.98 $85,551 - $104,009
1,030 Added 8.99%
12,486 $1.04 Million
Q4 2017

Feb 12, 2018

SELL
$93.56 - $116.6 $1.11 Million - $1.38 Million
-11,840 Reduced 50.82%
11,456 $1.09 Million
Q3 2017

Nov 13, 2017

BUY
$109.15 - $138.27 $2.54 Million - $3.22 Million
23,296
23,296 $2.72 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Tredje Ap Fonden Portfolio

Follow Tredje Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.